Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

Author： Horti J.   Juhasz E.   Monostori Z.   Maeda K.   Eckhardt S.   Bodrogi I.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.62, Iss.1, 2008-06, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses

By Tamura Kenji   Nakagawa Kazuhiko   Kurata Takayasu   Satoh Taroh   Nogami Toshiji   Takeda Koji   Mitsuoka Shigeki   Yoshimura Naruo   Kudoh Shinzoh   Negoro Shunichi   Fukuoka Masahiro  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 285-293

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer

By Kasai T.   Oka M.   Soda H.   Tsurutani J.   Fukuda M.   Nakamura Y.   Kawabata S.   Nakatomi K.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1871-1878

Elsevier

Access to resources Recommend Favorite

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

By Ono Yasushi   Hino Mitsunori   Ueda Yuka   Kamizuru Ryoko   Omata Masatoshi   Uehara Takashi   Tanaka Yosuke   Soma Tomoyuki   Kudoh Shoji  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 402-406

Humana Press, Inc

Access to resources Recommend Favorite

Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

By Tomonaga Nanae   Nakamura Yoichi   Soda Hiroshi   Nagashima Seiji   Nakano Hirofumi   Kinoshita Akitoshi   Fukuda Masaaki   Fukuda Minoru   Takatani Hiroshi   Soejima Yoshifumi   Oka Mikio   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 43-49

Springer Publishing Company

Access to resources Recommend Favorite

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

By Brunsvig Paal   Aamdal Steinar   Gjertsen Marianne   Kvalheim Gunnar   Markowski-Grimsrud Carrie   Sve Ingunn   Dyrhaug Marianne   Trachsel Sissel   Møller Mona   Eriksen Jon   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1553-1564

Springer Publishing Company

Access to resources Recommend Favorite